國立虎尾科技大學 |

Bisphosphonate Functionalized Gold Nanoparticles for the Study and Treatment of Osteoporotic Disease.

紀錄類型:	書目-語言資料,手稿 : Monograph/item
正題名/作者:	Bisphosphonate Functionalized Gold Nanoparticles for the Study and Treatment of Osteoporotic Disease./
作者:	Conners, Christopher M.
面頁冊數:	1 online resource (110 pages)
附註:	Source: Dissertation Abstracts International, Volume: 78-12(E), Section: B.
Contained By:	Dissertation Abstracts International78-12B(E).
標題:	Biomedical engineering. -
電子資源:	click for full text (PQDT)
ISBN:	9780355104431

Bisphosphonate Functionalized Gold Nanoparticles for the Study and Treatment of Osteoporotic Disease.
Conners, Christopher M.

Bisphosphonate Functionalized Gold Nanoparticles for the Study and Treatment of Osteoporotic Disease. - 1 online resource (110 pages)

Source: Dissertation Abstracts International, Volume: 78-12(E), Section: B.

Thesis (Ph.D.)--University of South Florida, 2017.

Includes bibliographical references

The use of nanoparticles for disease treatment is an increasingly popular area of research. The potential for multi-functionality allows nanoparticles to be used as transport and delivery vehicles for drugs and as diagnostic aides, among other applications, to address the unmet needs of many disease treatments. One such class of disease is osteoporosis including severe disorders, like Paget's disease, Osteogenesis Imperfecta and Legg Calve Perthes disease. In this dissertation, we discuss a nanoparticle system consisting of gold nanoparticles surface functionalized with primary amine bisphosphonates, which is a classification of pharmaceuticals that is common in the treatment of osteoporosis. Functionalized nanoparticles allow for greater intracellular concentrations of pharmaceutical, while the properties of the gold nanoparticles provide the ability to track the pharmaceutical and enhance imaging.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2018

Mode of access: World Wide Web

ISBN: 9780355104431Subjects--Topical Terms:

588770
Biomedical engineering.
Index Terms--Genre/Form:

554714
Electronic books.

Bisphosphonate Functionalized Gold Nanoparticles for the Study and Treatment of Osteoporotic Disease.
LDR:05002ntm a2200397Ki 4500 001 918933
005 20181106103643.5
006 m o u
007 cr mn||||a|a||
008 190606s2017 xx obm 000 0 eng d
020 $a 9780355104431
035 $a (MiAaPQ)AAI10604337
035 $a (MiAaPQ)usf:14288
035 $a AAI10604337
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Conners, Christopher M. $3 1193386
245 1 0 $a Bisphosphonate Functionalized Gold Nanoparticles for the Study and Treatment of Osteoporotic Disease.
264 0 $c 2017
300 $a 1 online resource (110 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertation Abstracts International, Volume: 78-12(E), Section: B.
500 $a Advisers: Vinay K. Gupta; Venkat Bhethanabotla.
502 $a Thesis (Ph.D.)--University of South Florida, 2017.
504 $a Includes bibliographical references
520 $a The use of nanoparticles for disease treatment is an increasingly popular area of research. The potential for multi-functionality allows nanoparticles to be used as transport and delivery vehicles for drugs and as diagnostic aides, among other applications, to address the unmet needs of many disease treatments. One such class of disease is osteoporosis including severe disorders, like Paget's disease, Osteogenesis Imperfecta and Legg Calve Perthes disease. In this dissertation, we discuss a nanoparticle system consisting of gold nanoparticles surface functionalized with primary amine bisphosphonates, which is a classification of pharmaceuticals that is common in the treatment of osteoporosis. Functionalized nanoparticles allow for greater intracellular concentrations of pharmaceutical, while the properties of the gold nanoparticles provide the ability to track the pharmaceutical and enhance imaging.
520 $a We have synthesized and characterized bisphosphonate functionalized gold nanoparticles of controlled size of approximately 15 nm, which are suitable for cellular uptake, and functionalized the surface using self-assembly with pamidronate and alendronate. In one major finding of this study, inductively coupled plasma mass spectrometry was used to estimate approximate surface density of the bisphosphonates on the gold nanoparticles. This resulted in concentrations of approximately 0.65 molecules per nm2 (approximately 154 A2/molecule) for pamidronate functionalized on gold, and approximately 2.6 molecules per nm2 (approximately 39 A 2/molecule) for alendronate functionalized on gold. This allows for more accurate estimates of pharmaceutical concentrations, during in vitro and in vivo studies.
520 $a Additionally, we investigated the effects of bisphosphonate functionalized gold nanoparticles on the viability and morphology of osteoclast and osteoblast cells in vitro. We found that attaching the bisphosphonates to the surface of the nanoparticles leads to increased apoptotic effects of the bisphosphonates on the osteoclast cells compared to free bisphosphonates. Further, we showed bisphosphonate functionalized gold nanoparticles may have an effect on nuclei morphology that may provide an additional means of modulating bone resorption rather than just through influencing viability. Further we showed that it may be possible to target concentrations that are safe for osteoblasts, which is critical in determining potential treatment concentrations. These viability results bring to light a number of potential considerations into the optimization of potential treatments, such as dosing concentrations.
520 $a Finally, detailed results are given on effects of bisphosphonate functionalized gold nanoparticles on important behavior and activity of osteoclast and osteoblast cells in vitro. We showed that while using concentrations below the toxicity threshold, some of the normal activity of the cells could be maintained. RANKL and ALP expression in osteoblasts were maintained when removing viability as a variable. Additionally, bone nodule formation was also maintained for osteoblasts and co-cultured in vitro systems. Finally, we showed that the introduction of bone in the in vitro studies adds a new degree of consideration as to the interaction of the bisphosphonates with the hydroxyapatite surface. This strong interaction with bone is an important consideration in further developing potential treatments for osteoporotic disease.
520 $a This dissertation provides insights into the use of bisphosphonate functionalized gold nanoparticles as a potential treatment and means of study for bone remodeling disorders.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2018
538 $a Mode of access: World Wide Web
650 4 $a Biomedical engineering. $3 588770
650 4 $a Nanoscience. $3 632473
650 4 $a Medicine. $3 644133
655 7 $a Electronic books. $2 local $3 554714
690 $a 0541
690 $a 0565
690 $a 0564
710 2 $a ProQuest Information and Learning Co. $3 1178819
710 2 $a University of South Florida. $b Chemical Engineering. $3 1193387
773 0 $t Dissertation Abstracts International $g 78-12B(E).
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10604337 $z click for full text (PQDT)